about
New insights on the development of fungal vaccines: from immunity to recent challengesGeneration of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans.A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis.Antibody response to Cryptococcus neoformans proteins in rodents and humans.Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Fungal cell wall vaccines: an update.Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens.Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity.
P2860
Q26776056-520858B4-E43A-4666-BDDB-877F4B8BA5AEQ30964858-347C375E-AA64-49A9-8110-D1A0513C1502Q33753864-788D5B3A-9C71-4479-91B4-6BB350BF180DQ33867027-0F289639-6F33-4374-898F-6CAE0455EEECQ34003262-5BE0F1DA-48C8-4927-9D61-4FD90F7C9823Q34007719-819089AE-C85C-4F5E-98CB-A74DE5FCD70EQ34131697-EE956A07-E7DB-4F41-B484-9D2C647FC6B1Q36525342-2C524113-C43B-45B2-807F-5BB1D8413B64Q37116545-3924A97C-B16A-4B40-AF12-ED09E34DC12EQ39513945-EF41ACE7-AEC0-4184-AF81-D85BF8697AD3Q39519765-FA0E2B24-2546-40DC-9B2A-53339EA18814Q41817239-32935BA5-57FE-41FE-8DD3-6DF1DD7B2C63
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Prospects for the development of fungal vaccines.
@en
Prospects for the development of fungal vaccines.
@nl
type
label
Prospects for the development of fungal vaccines.
@en
Prospects for the development of fungal vaccines.
@nl
prefLabel
Prospects for the development of fungal vaccines.
@en
Prospects for the development of fungal vaccines.
@nl
P2860
P356
P1476
Prospects for the development of fungal vaccines
@en
P2093
P2860
P304
P356
10.1128/CMR.10.4.585
P407
P577
1997-10-01T00:00:00Z